Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G R Matzke

Showing results (51-60 of 124) with videos related to

Pageof 13
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 18, 1998
Cefazolin as empiric therapy in hemodialysis-related infections: efficacy and blood concentrationsM A Marx, R F Frye, G R Matzke, et al.
Clinical Pharmacology and Therapeutics|October 1, 1986
Disposition of vancomycin during hemofiltrationG R Matzke, M B O'Connell, A J Collins, et al.
Clinical Chemistry|August 1, 1987
Improved liquid-chromatographic assay of labetalol in plasmaD R Luke, G R Matzke, J T Clarkson, et al.
Clinical Pharmacy|May 1, 1985
Evaluation of the vancomycin-clearance:creatinine-clearance relationship for predicting vancomycin dosageG R Matzke, J M Kovarik, M J Rybak, et al.
Journal of Clinical Hypertension|December 1, 1987
Comparison of antihypertensive, renal hemodynamic, and humoral effects of pinacidil and hydralazine monotherapyP A Abraham, C E Halstenson, G R Matzke, et al.
Clinical Pharmacy|May 1, 1989
Vancomycin disposition during continuous arteriovenous hemofiltrationR E Dupuis, G R Matzke, F W Maddux, et al.
Research Communications in Chemical Pathology and Pharmacology|October 1, 1986
Lack of pharmacodynamic interaction between pentoxifylline and warfarin in the ratD R Luke, M P O'Donnell, W F Keane, et al.
Pharmacotherapy|June 15, 2000
Determinants of ceftriaxone clearance by continuous venovenous hemofiltration and hemodialysisG R Matzke, R F Frye, M S Joy, et al.
Clinical Nephrology|November 1, 1984
Trimethoprim-sulfamethoxazole pharmacokinetics during continuous ambulatory peritoneal dialysisC E Halstenson, R B Blevins, N G Salem, et al.
Clinical Pharmacology and Therapeutics|July 1, 1985
Cefotaxime and desacetyl cefotaxime kinetics in renal impairmentG R Matzke, P A Abraham, C E Halstenson, et al.
Pageof 13

Showing results (51-60 of 124) with videos related to

Sort By:
Pageof 13
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 18, 1998
Cefazolin as empiric therapy in hemodialysis-related infections: efficacy and blood concentrationsM A Marx, R F Frye, G R Matzke, et al.
Clinical Pharmacology and Therapeutics|October 1, 1986
Disposition of vancomycin during hemofiltrationG R Matzke, M B O'Connell, A J Collins, et al.
Clinical Chemistry|August 1, 1987
Improved liquid-chromatographic assay of labetalol in plasmaD R Luke, G R Matzke, J T Clarkson, et al.
Clinical Pharmacy|May 1, 1985
Evaluation of the vancomycin-clearance:creatinine-clearance relationship for predicting vancomycin dosageG R Matzke, J M Kovarik, M J Rybak, et al.
Journal of Clinical Hypertension|December 1, 1987
Comparison of antihypertensive, renal hemodynamic, and humoral effects of pinacidil and hydralazine monotherapyP A Abraham, C E Halstenson, G R Matzke, et al.
Clinical Pharmacy|May 1, 1989
Vancomycin disposition during continuous arteriovenous hemofiltrationR E Dupuis, G R Matzke, F W Maddux, et al.
Research Communications in Chemical Pathology and Pharmacology|October 1, 1986
Lack of pharmacodynamic interaction between pentoxifylline and warfarin in the ratD R Luke, M P O'Donnell, W F Keane, et al.
Pharmacotherapy|June 15, 2000
Determinants of ceftriaxone clearance by continuous venovenous hemofiltration and hemodialysisG R Matzke, R F Frye, M S Joy, et al.
Clinical Nephrology|November 1, 1984
Trimethoprim-sulfamethoxazole pharmacokinetics during continuous ambulatory peritoneal dialysisC E Halstenson, R B Blevins, N G Salem, et al.
Clinical Pharmacology and Therapeutics|July 1, 1985
Cefotaxime and desacetyl cefotaxime kinetics in renal impairmentG R Matzke, P A Abraham, C E Halstenson, et al.
Pageof 13